ID   HCA1
AC   CVCL_2916
SY   HCA-1
DR   BioSample; SAMN03470914
DR   BioSample; SAMN03472467
DR   cancercelllines; CVCL_2916
DR   Cell_Model_Passport; SIDM01813
DR   DepMap; ACH-001513
DR   JCRB; JCRB1153
DR   JCRB; NIHS0406
DR   Wikidata; Q54881487
RX   CelloPub=CLPUB00777;
RX   PubMed=24403450;
RX   PubMed=25877200;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Doubling time: 26.4 hours (CelloPub=CLPUB00777); 21 hours (PubMed=24403450).
CC   Discontinued: JCRB; NIHS0406; true.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): DepMap=ACH-001513; JCRB=JCRB1153; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 11
ST   D18S51: 15
ST   D19S433: 14
ST   D21S11: 32.2
ST   D2S1338: 24
ST   D3S1358: 17
ST   D5S818: 11
ST   D7S820: 10,11
ST   D8S1179: 11,14
ST   FGA: 23
ST   Penta D: 10
ST   Penta E: 18,21
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C4029; Cervical adenocarcinoma
DI   ORDO; Orphanet_213772; Adenocarcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 16
//
RX   CelloPub=CLPUB00777;
RA   Shimoda T., Kuramoto H.;
RT   "HCA-1.";
RL   Hum. Cell 1:455-455(1988).
//
RX   PubMed=24403450;
RA   Torii Y., Kato R., Minami Y., Hasegawa K., Fujii T., Udagawa Y.;
RT   "ERCC1 expression and chemosensitivity in uterine cervical
RT   adenocarcinoma cells.";
RL   Anticancer Res. 34:107-115(2014).
//
RX   PubMed=25877200; DOI=10.1038/nature14397;
RA   Yu M., Selvaraj S.K., Liang-Chu M.M.Y., Aghajani S., Busse M.,
RA   Yuan J., Lee G., Peale F.V., Klijn C., Bourgon R., Kaminker J.S.,
RA   Neve R.M.;
RT   "A resource for cell line authentication, annotation and quality
RT   control.";
RL   Nature 520:307-311(2015).
//